UK NICE · June 24, 2026

New treatment option recommended for recurrent or metastatic cervical cancer

NICE recommends a new treatment for recurrent or metastatic cervical cancer for NHS funding.

Low obligation Product class Pharmaceuticals Market Access & Reimbursement UK Reimbursement

A new treatment option is now available on the NHS for cervical cancer that has come back or spread to other parts of the body, following our final draft guidance published today.

Read the official source ↗

Published by UK NICE. HealthSignal links to the original document; the summary above is extracted from the source text.